These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 25088287)

  • 1. Associations between mood, anxiety or substance use disorders and inflammatory markers after adjustment for multiple covariates in a population-based study.
    Glaus J; Vandeleur CL; von Känel R; Lasserre AM; Strippoli MP; Gholam-Rezaee M; Castelao E; Marques-Vidal P; Bovet P; Merikangas K; Mooser V; Waeber G; Vollenweider P; Aubry JM; Preisig M
    J Psychiatr Res; 2014 Nov; 58():36-45. PubMed ID: 25088287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mood disorders and circulating levels of inflammatory markers in a longitudinal population-based study.
    Glaus J; von Känel R; Lasserre AM; Strippoli MF; Vandeleur CL; Castelao E; Gholam-Rezaee M; Marangoni C; Wagner EN; Marques-Vidal P; Waeber G; Vollenweider P; Preisig M; Merikangas KR
    Psychol Med; 2018 Apr; 48(6):961-973. PubMed ID: 28929992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations of obesity with psychiatric disorders and suicidal behaviors in a nationally representative sample.
    Mather AA; Cox BJ; Enns MW; Sareen J
    J Psychosom Res; 2009 Apr; 66(4):277-85. PubMed ID: 19302884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of mood, anxiety, and substance-abuse disorders for older Americans in the national comorbidity survey-replication.
    Gum AM; King-Kallimanis B; Kohn R
    Am J Geriatr Psychiatry; 2009 Sep; 17(9):769-81. PubMed ID: 19700949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prevalence and age of onset of psychiatric disorders in Australian men.
    Williams LJ; Jacka FN; Pasco JA; Coulson CE; Quirk SE; Stuart AL; Berk M
    Aust N Z J Psychiatry; 2016 Jul; 50(7):678-84. PubMed ID: 26546500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
    Liraud F; Verdoux H
    Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-medication of mood disorders with alcohol and drugs in the National Epidemiologic Survey on Alcohol and Related Conditions.
    Bolton JM; Robinson J; Sareen J
    J Affect Disord; 2009 Jun; 115(3):367-75. PubMed ID: 19004504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temporal sequencing of lifetime mood disorders in relation to comorbid anxiety and substance use disorders--findings from the Netherlands Mental Health Survey and Incidence Study.
    de Graaf R; Bijl RV; Spijker J; Beekman AT; Vollebergh WA
    Soc Psychiatry Psychiatr Epidemiol; 2003 Jan; 38(1):1-11. PubMed ID: 12563553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic obstructive lung diseases and prevalence of mood, anxiety, and substance-use disorders in a large population sample.
    Patten SB; Williams JV
    Psychosomatics; 2007; 48(6):496-501. PubMed ID: 18071096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Childhood life events, immune activation and the development of mood and anxiety disorders: the TRAILS study.
    Jonker I; Rosmalen JGM; Schoevers RA
    Transl Psychiatry; 2017 May; 7(5):e1112. PubMed ID: 28463238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The specific burden of comorbid anxiety disorders and of substance use disorders in bipolar I disorder.
    Goldstein BI; Levitt AJ
    Bipolar Disord; 2008 Feb; 10(1):67-78. PubMed ID: 18199243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The bidirectional relationship between anxiety disorders and circulating levels of inflammatory markers: Results from a large longitudinal population-based study.
    Glaus J; von Känel R; Lasserre AM; Strippoli MF; Vandeleur CL; Castelao E; Gholam-Rezaee M; Marangoni C; Wagner EN; Marques-Vidal P; Waeber G; Vollenweider P; Preisig M; Merikangas KR
    Depress Anxiety; 2018 Apr; 35(4):360-371. PubMed ID: 29244900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathways to comorbidity: the transition of pure mood, anxiety and substance use disorders into comorbid conditions in a longitudinal population-based study.
    de Graaf R; Bijl RV; Ten Have M; Beekman AT; Vollebergh WA
    J Affect Disord; 2004 Nov; 82(3):461-7. PubMed ID: 15555699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age at immigration to Canada and the occurrence of mood, anxiety, and substance use disorders.
    Patterson B; Kyu HH; Georgiades K
    Can J Psychiatry; 2013 Apr; 58(4):210-7. PubMed ID: 23547644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse childhood experiences in relation to mood and anxiety disorders in a population-based sample of active military personnel.
    Sareen J; Henriksen CA; Bolton SL; Afifi TO; Stein MB; Asmundson GJ
    Psychol Med; 2013 Jan; 43(1):73-84. PubMed ID: 22608015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of psychiatric disorders in community-dwelling older men and women with cognitive impairment no dementia: results from the ESA study.
    Potvin O; Hudon C; Forget H; Grenier S; Dubé M; Lorrain D; Préville M
    Aging Ment Health; 2012; 16(2):218-27. PubMed ID: 21702708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of mood, anxiety, and substance use disorders with occupational status and disability in a community sample.
    el-Guebaly N; Currie S; Williams J; Wang J; Beck CA; Maxwell C; Patten SB
    Psychiatr Serv; 2007 May; 58(5):659-67. PubMed ID: 17463347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of anxiety disorders in the Australian general population: findings of the 2007 Australian National Survey of Mental Health and Wellbeing.
    McEvoy PM; Grove R; Slade T
    Aust N Z J Psychiatry; 2011 Nov; 45(11):957-67. PubMed ID: 22044173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychiatric disorders and association with quality of sleep and quality of life in patients with chronic pain: a SCID-based study.
    Annagür BB; Uguz F; Apiliogullari S; Kara I; Gunduz S
    Pain Med; 2014 May; 15(5):772-81. PubMed ID: 24612225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of substance use disorder on the clinical presentation of anxiety and depression in an outpatient psychiatric clinic.
    Tsuang D; Cowley D; Ries R; Dunner DL; Roy-Byrne PP
    J Clin Psychiatry; 1995 Dec; 56(12):549-55. PubMed ID: 8530330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.